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ABSTRACT
EphA/ephrin-A mediated signaling has emerged as a key mechanism regulating 
axon guidance and topographic mapping, particularly in the well-characterized visual 
system from the retina to the superior colliculus (SC). In this study, EphA8 bacterial 
artificial chromosome (BAC) was manipulated to contain a floxed eGFP and human 
ephrin-A5 expression cassette using homologous recombination method. In the mice 
containing the recombinant BAC, it was shown that GFP is expressed in an anterior＞
posterior gradient in the SC. Furthermore, when these mice were crossed with the 
transgenic mice expressing Cre under the EphA8 promoter, it was evident that a GFP 
expression cassette was eliminated, and that human ephrin-A5 was ectopically ex-
pressed in the anterior region of the SC. This transgenic model would be useful to 
analyze the role of ephrin-A5 in the SC during the retinocollicular topography formation.
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INTRODUCTION
    Recent  studies  indicate  that  Eph  receptors  and 
ephrins coordinate various developmental processes 
but  also  physiological  events  and  homeostasis  of 
diverse adult organs (Klein, 2004; Pasquale, 2008). 
These  emerging  Eph-ephrin  functions  suggest  that 
the  unbalanced  signaling  of  these  molecules  may 
lead to the genesis of a variety of diseases such as 
diabetes  and  cancer.  An  intriguing  feature  of  Eph/ 
ephrin  signaling  is  that  Ephs  and  ephrins  are 
mutually  exclusively  expressed  and  that  they  elicit 
bidirectional  signaling  between  two  opposing  cells 
through  cell-cell  contact  (Davy  and  Soriano,  2005). 
However,  in  some  cases,  Ephs  and  ephrins  are 
co-expressed  in  the  same  cells.  For  example,  it 
was  shown  that  co-expression  of  ephrin-As  with 
EphAs  in  the  nasal  retinal  ganglion  cells  reduced 
the  sensitivity  of  EphAs  towards  ephrinAs  ex-
pressed  in  the  posterior  region  of  the  superior 
colliculus  (Hornberger  et  al.,  1999).  In  addition, 
formation  of  the  cis  Eph-ephrin  complex  within  the 
same  cell  was  shown  to  cause  an  abolishment  of 
the  tyrosine  phosphorylation  of  EphA3,  thereby 
leading  to  a  loss  of  sensitivity  towards  ephrin-As 
applied  in  trans  (Carvalho  et  al.,  2006).  These 
results  suggest  that  co-expression  of  Ephs  and 
ephrins  impairs  their  signaling  through  cis-interact-
ion.  In  contrast,  another  study  demonstrated  that 
EphAs and ephrinAs are localized to different mem-
brane  domains  and  signal  independently.  They 50 H y u n a  N o h ,  e t  a l .
showed that EphA forward signaling directed growth 
cone  collapse  and  retraction  while  ephrinA  reverse 
signaling  motor  axon  growth  and  attraction  (Mar-
quardt  et  al.,  2005).
    In  this  study,  we  generated  a  transgenic  mice 
ectopically  expressing  ephrin-A5  at  the  anterior 
superior  colliculus  (SC)  where  various  EphA  recep-
tors are normally expressed with anterior＞posterior 
gradient  (Lemke  and  Reber,  2005).  These  mice 
may  be  a  valuable  tool  to  elucidate  whether 
ephrin-As acts as an inhibitor or independent ligand 
in  the  anterior  SC  during  the  retinocollicular  topo-
graphy  formation.
MATERIALS  AND  METHODS
Generation  of  BAC  transgenic  mice
    Construction  of  targeting  vector,  homologous 
recombination  and  Southern  analyses  were  per-
formed  as  described  previously  (Kim  et  al.,  2007). 
BAC  transgenic  mice  containing  EphA8-eGFP  were 
genotyped  by  PCR  using  the  following  primers: 
5’-TCTTGCCAGCTCTACCACCA-3’  and  5’-CAGA-
GAACTTCAGCGGTCCA-3’.  BAC  transgenic  mice 
containing  EphA8-Cre  mice  were  also  identified  by 
PCR  using  the  primers  5’-CAGGATATCGTAATC-
TGGCATTTC-3’ and 5’-ATGACAATATTTACATTGG-
TCCAGC-3’.
Histology  and  immunohistochemistry
    The mice were perfused with 4% PFA in 1× PBS 
and  the  brains  were  post-fixed  for  2  hr  in  cold  4% 
PFA  in  1×  PBS,  washed  three  times  for  20  min 
each  with  PBS,  incubated  in  30%  sucrose  in  1× 
PBS  for  overnight  at  4
oC  and  then  embedded  in 
tissue  freezing  medium  (Jung).  Sections  (20μm) 
were  stored  at  −20
oC  or  −80
oC.  For  the  antibody 
staining,  the  sections  were  washed  two  times  in 
0.1%  Triton  X-100/PBS  (10  minutes  each),  blocked 
with 10% Horse serum, 0.1% Triton X-100/PBS 1 hr 
at  room  temperature.  The  primary  antibody  was 
diluted  in  blocking  solution  and  incubated  at  4
oC 
overnight.  Goat  anti-human  ephrin-A5  antibody  was 
purchased  from  R  and  D  system.  After  three  times 
washes  in  0.1%  Triton  X-100/PBS  (30  minutes 
each),  the  secondary  antibody,  diluted  in  blocking 
solution, was applied for 3 hr (FITC-conjugated rab-
bit anti-goat, chemicon, 1：200). After three washes 
with  0.1%  Triton  X-100/PBS,  counterstaining  was 
performed  with  DAPI  and  the  sections  were 
embedded  with  vectasheild  (Vectorlab).
RESULTS
Construction  of  a  recombinant  EphA8  bac-
terial  artificial  chromosome  (BAC)  containing 
a  eGFP-ephrinA5  expression  cassette 
    Previous  studies  showed  that  co-expressed  Eph 
receptors  and  ephrin  ligands  negatively  regulate  its 
biological  function  or  mediate  opposing  actions  on 
their  counter-partners  presented  in  trans  (McLaugh-
lin  and  O'Leary,  2005).  To  investigate  whether  co- 
expression  of  ephrin-A5  in  the  EphA8-expressing 
superior  collicular  cells  affects  the  retinocollicular 
topography,  we  modified  a  EphA8  BAC  clone, 
RP23-357K18,  which  is  shown  to  express  LacZ 
reporter  gene  in  the  anterior  region  of  the  superior 
colliculus  (SC)  but  not  in  the  retina  (Kim  et  al., 
2007). Because the EphA8 gene contains 17 exons, 
is  about  28  kb  in  length  and  located  in  the  center 
of  the  EphA8  BAC  clone,  it  is  expected  that 
RP23-357K18  clone  contains  the  regulatory  ele-
ments  and  locus  control  regions  necessary  to  reca-
pitulate the endogenous expression of EphA8 in vivo.
    In  order  to  insert  the  eGFP-ephrinA5  expression 
cassette  into  the  first  exon  of  EphA8  in  the  BAC 
clone,  we  constructed  a  targeting  vector  containing 
a 1.2 kb EphA8 genomic DNA upstream of the first 
exon,  eGFP  flanked  by  two  loxP  sites,  a  human 
ephrin-A5  cDNA,  kanamycin  resistance  gene  flank-
ed by two FRT sites, and a 0.7 kb EphA8 genomic 
DNA  downstream  of  the  first  exon  (Fig.  1).  This 
targeting  vector  was  transformed  into  the  bacteria 
carrying  the  EphA8  BAC  DNA  and  pKOBEGA 
plasmid  containing  an  inducible  lamda  phage  re-
combinase  system.  To  induce  the  recombinases, 
bacteria  were  incubated  in  arabinose-containing 
medium,  and  the  first  recombinant  BAC  clones 
were  selected  in  the  presence  of  chloramphenicol 
and  kanamycin.  Southern  blot  analysis  using  GFP 
as  a  probe  revealed  that  a  9.6  kb  KpnI  fragment 
was  detected  in  the  wild  type  BAC,  whereas  a  8.2 
kb  fragment  was  detected  in  the  first  recombinant 
BAC  DNA  (data  not  shown).  When  Southern  blot 
analysis  was  performed  using  ephrinA5  cDNA  as  a 
probe,  a  7.1  kb  fragment  was  detected  in  the  first Ectopic  Expression  of  Ephrin-A5 51
Fig.  1.  Strategy  for  constructing  a 
recombinant  EphA8  BAC  containing 
a  eGFP-human  ephrinA5  expression 
cassette.  The  EphA8  BAC  clone, 
RP23-357K18, contains approximate-
ly  286.6  kb  genomic  DNA,  and  the 
ephA8 gene is positioned approxima-
tely  in  the  middle  of  the  BAC  clone. 
The ephA8 gene is approximately 28 
kb  long  as  represented  by  a  thin 
line, and it comprises 17 exons. The 
targeting  vector  was  designed  to 
contain  two  ephA8  genomic  DNAs 
on  its  either  side,  which  allow  a 
specific  homologous  recombination 
between the targeting vector and the 
EphA8  BAC  DNA  at  the  genomic 
region  surrounding  the  first  exon. 
The  floxed  eGFP-human  ephrinA5 
cDNA expression cassette and kana-
mycin  resistance  gene  flanked  by 
FRT  sites  were  also  inserted  in 
between  two  homologous  genomic 
arms of the targeting vector. Through 
the  first  homologous  recombination, 
the  eGFP-human  ephrinA5  cDNA 
and  kanamycin  resistance  cassette 
was  inserted  into  the  first  ephA8 
exon  in  the  EphA8  BAC  clone. 
Then, the kanamycin resistance cas-
sette  was  selectively  eliminated  by 
expressing  Flipase,  leading  to  the 
EphA8-eFFP  BAC  clone  containing 
only  the  floxed  eGFP-human  eph-
rinA5  cDNA  expression  cassette. 
Finally,  it  was  expected  that  the 
expression  Cre  recombinase  elimi-
nate  the  floxed  eGFP  from  the 
EphA8-eGFP  BAC  clone  and  that 
the  EphA8-ephrinA5  BAC  express 
human  ephrin-A5  instead  of  eGFP 
under  the  EphA8  promoter.  K:  kpnI.
recombinant BAC clone, whereas a 9.6 kb fragment 
was  detected  in  the  wild  type  BAC  clone  (data  not 
shown).  To  eliminate  the  kanamycine  resistance 
cassette from the first recombinant BAC clone, FLP 
plasmid was electroporated into cells containing the 
first  recombinant  BAC  clone,  selected  at  30
oC  in 
the  presence  of  chloramphenicol,  kanamycin  and 
tetracycline,  and  then  flipase  was  induced  by 
shifting temperature to 42
oC to eliminate a kanamy-
cin  cassette  between  two  FRT  sites.  To  confirm 
EphA8-eGFP  recombinant,  we  performed  Southern 
blot  analysis  using  ephrinA5  as  a  probe,  revealing 
that a 5.0 kb KpnI digested fragment was detected 
in  the  final  recombinant  BAC  clone  (data  not 
shown).52 H y u n a  N o h ,  e t  a l .
Fig.  2.  Expression  analysis  of  eGFP  at  the  anterior  region  of  the 
superior  colliculus.  (A)  Transgenic  mice  containing  EphA8-eGFP 
BAC  were  crossed  with  those  containing  EphA8-Cre  BAC.  The 
midbrains were isolated from each littermate at P5 and the dorsal 
region  of  each  midbrain  was  visualized  with  GFP  fluorescence. 
The wild type mice did not show any GFP signal in the SC (the 
first panel),  whereas  the  EphA8-eGFP  mice revealed  an  anterior 
＞posterior  gradient  expression  of  GFP  at  the  SC  (the  second 
panel).  In  addition,  GFP  signal  was  barely  detectable  in  the  SC o f  
the  compound  transgenic  line  containing  both  eGFP-ephrinA5  and 
Cre  (the  third  panel).  (B)  PCR  genotyping  was  performed  using  tail 
genomic  DNAs  derived  from  each  littermate  (the  first  and  second 
panels).  Primers  were  designed  to  amplify  a  portion  of  human 
ephrin-A5  cDNA,  which  is  expected  to  produce  a  450  bp  PCR 
product  in  each  transgenic  line  but  not  wild  type  mice  (the  first 
panel).  Likewise,  primers  were  designed  to  amplify  a  portion  of C r e 
gene,  which  is  expected  to  produce  a  500  bp  PCR  product  only  in 
a compound transgenic line containing both eGFP-ephrinA5 and Cre 
(the second panel). RT-PCR analysis was also performed to identify 
the  expression  of  human  ephrin-A5  in  a  compound  transgenic  line. 
RNAs  were  purified  from  the  SC  extract  of  each  littermate  and  the 
same primers for human ephrin-A5 PCR genotyping (the first panel) 
were used for RT-PCR analysis (the third panel). The expected 450 
bp  RT-PCR  product  was  detected  only  in  the  presence  of  RT  from 
the  SC  of  the  compound  transgenic  line  (lane  4).  SC:  superior 
colliculus,  IC:  inferior  colliculus,  RT:  reverse  transcriptase.
Fig.  3.  Expression  analysis  of  human  ephrin-A5  at  the  anterior 
region  of  the  superior  colliculus.  (A∼C)  Immunohistochemical 
analyses  of  ephrin-A5  proteins  in  the  sagittal sections  of  the  SC 
from the wild type littermate. Note that the endogenous ephrinA5 
was detectable in the posterior SC but not in the anterior SC. (D
∼F)  Immunohistochemical  analyses  of  ephrin-A5  proteins  in  the 
sagittal  sections  of  the  SC  from  the  transgenic  littermate 
expressing  human  ephrin-A5  under  the  EphA8  promoter.  In 
contrast  to  the  wild  type  littermate,  ephrin-A5  proteins  were 
detectable in both anterior and posterior regions of the SC in the 
transgenic  line.
Generation  of  BAC  transgenic  lines  express-
ing eGFP or human ephrinA5 under the EphA8 
promoter
    Next,  EphA8-eGFP  BAC  clone  was  injected  into 
a  fertilized  ICR  mouse  zygote  to  generate  BAC 
transgenic mice expressing eGFP under the EphA8 
promoter.  Transgenic  mice  containing  the  EphA8- 
eGFP  BAC  DNA  were  directly  confirmed  by  PCR 
genotyping as shown in Fig. 2B (first panel, lane 2). 
To  investigate  whether  the  transgenic  line  express 
eGFP under the EphA8 promoter, we dissected out 
the superior colliculus (SC) from postnatal (P) 5 day 
mice and then observed the GFP expression under 
the  fluorescent  microscope.  As  shown  in  Fig.  2A, 
eGFP  was  detected  as  an  anterior＞posterior  grad-
ient  in  the  SC  of  the  transgenic  mice  (the  second 
panel),  which  is  very  similar  to  the  endogenous 
expression pattern of EphA8 in the SC. In contrast, 
eGFP was not detectable in the SC of the wild type 
littermate  (Fig.  2A,  the  first  panel).
    To  further  analyze  whether  the  floxed  eGFP  in 
the  EphA8-eGFP  transgenic  mice  is  effectively 
eliminated  by  Cre  recombinase,  we  generated  a 
EphA8-Cre  transgenic  line  using  the  same  EphA8 
BAC  clone  described  in  Fig.  1,  where  P1  bacterio-
phage  Cre  DNA  was  specifically  inserted  into  the 
first exon of EphA8. This EphA8-Cre transgenic line 
was crossed with the EphA8-eGFP BAC transgenic 
line  to  generate  a  compound  transgenic  line 
expressing  both  human  ephrin-A5  and  Cre  under 
the  EphA8  promoter  (see  EphA8-ephrinA5  in  Fig. 
1).  It  was  evident  that  this  compound  transgenic 
line  contained  both  EphA8-eGFP  and  EphA8-Cre 
BAC  clones,  based  on  PCR  genotyping  (Fig.  2B, Ectopic  Expression  of  Ephrin-A5 53
the  first  and  second  panels,  lane  3).  In  addition, 
eGFP  expression  was  barely  detectable  in  the  SC 
of the compound transgenic line, indicating that the 
floxed  eGFP  expression  module  was  efficiently 
eliminated  by  Cre  recombinase  in  the  SC  (Fig.  2A, 
third  panel).  To  further  confirm  whether  human 
ephrin-A5  is  expressed  under  the  EphA8  promoter, 
we  performed  RT-PCR  analysis  using  total  RNAs 
isolated  from  the  SC  extracts,  where  the  primers 
were designed to specifically amplify human ephrin- 
A5  cDNA  but  not  mouse  ephrin-A5  cDNA.  As 
expected,  a  PCR  product  corresponding  to  human 
ephrin-A5  gene  was  detected  only  in  the  SC  of  a 
compound  transgenic  line  but  not  its  wild  type 
littermate  (Fig.  2B,  third  panel,  lane  4).
Expression  analysis  of  human  ephrin-A5  in  the 
anterior region of the mouse superior colliculus
    To  further  investigate  whether  human  ephrinA5 
cDNA in the compound transgenic mice is express-
ed in the anterior region of the SC, we prepared a 
series  of  cryosections  for  immmunohistochemistry 
using  anti-ephrinA5  antibody.  As  expected,  in  the 
wild  type  littermate,  the  endogenous  ephrin-A5  was 
abundantly  expressed  in  the posterior region  of the 
SC  but  also  in  the  inferior  colliculus  (IC)  (Fig.  3A, 
C).  However,  ephrinA5  was  not  detectable  in  the 
anterior  SC  of  the  wild  type  mice  (Fig.  3B).  In 
contrast,  ephrin-A5  was  detectable  in  both  anterior 
and  posterior SC  of the  compound transgenic  mice 
(Fig.  3D∼F).  These  results  demonstrate  that  the 
compound  transgenic  mice  containing  both  EphA8- 
eGFP  and  EphA8-Cre  BAC  clones  do  ectopically 
express  human  ephrin-  A5  under  the  EphA8  pro-
moter  in  the  anterior  region  of  the  SC.
DISCUSSION
    In  the  present  study,  we  generated  BAC  transgenic 
mice  expressing  human  ephrin-A5  under  the  EphA8 
promoter. It was evident that human ephrin- A5 cDNA 
was  ectopically  expressed  at  the  anterior  part  of  the 
SC.  However,  unlike  other  studies,  we  were  not  able 
to  observe  any  altered  size  or  morphology  of  the  SC 
in  those  transgenic  mice  despite  the  co-expression  of 
ephrin-A5  with  EphA  receptors,  suggesting  that  mis- 
expression  of  ephrin-  A5  does  not  affect  cell  pro-
liferation  or  cell  survival  at  least  in  the  SC  (Depaepe 
et  al.,  2005).  Nevertheless,  these  transgenic  mice 
might  be  an  ideal  animal  model  to  determine  the 
function of ephrin-A5 in the retinocollicular topography. 
If  the  ectopic  ephrin-A5  acted  as  a  barrier  for  the 
growth of EphA-expressing retinal ganglion cell (RGC) 
axons,  it  would  be  expected  that  the  number  of  RGC 
axons is significantly reduced in the SC. If the ectopic 
ephrin-A5  acted  as  a  ligand  for  EphA  receptors,  the 
retinocollicular topography would be significantly altered.
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